Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 16/20 | 0.57 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | ALPI | P09923 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | XIAP | P98170 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7314907 | 0.85 | KIF11 (0.55) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7323114 | 0.85 | KIF11 (0.55) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7321995 | 0.83 | KIF11 (0.46) | KIF11SLC1A5 | |
| SCHEMBL7324156 | 0.82 | KIF11 (0.50) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7311886 | 0.82 | KIF11 (0.43) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7326141 | 0.81 | KIF11 (0.42) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7314653 | 0.81 | SLC6A1 (0.46) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7317519 | 0.81 | SLC6A1 (0.46) | KIF11SLC1A5IDO1ALPIPKM | |
| SCHEMBL7318407 | 0.76 | KIF11 (0.59) | KIF11SLC1A5 | |
| SCHEMBL7326122 | 0.76 | KIF11 (0.59) | KIF11SLC1A5IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | disclosed |